Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, we, the blinded ones, are now obviously not the only ones that see the data as good. But say what you will, it’s the results that really matter.
Damn, who cares what the CEO does with his money? Every advisor out there says to not have your wealth tied up in the company you work for and there is the additional factor of this being a baby bio startup with no guarantees as all of the fudsters point out daily. Let it go, please.
Another 200k at the close.
No, most investors are holding and buying more on these drops. We know what we own!
Below you can see three licensing deals by Biogen that had much larger up front payments:
From Fierce Bio JPM Week
That said, all three of Biogen's deals—with Sage, Sangamo and Denali Therapeutics, worth around $8 billion altogether—are high risk, too, given the challenges of operating in neurosciences. A hefty $2.8 billion of that total was paid upfront.
After the last week and finally getting to read Jesses review of the data and his observations / conversations, I finally feel vindicated in my choice to stay in this stock for 10 years. I personally hope we don’t get any additional news unless it includes a partnership or some form of approval somewhere in the world. The haters can’t put a viable hit piece out if the release includes that news. Thanks Jesse for setting my mind at ease. Great piece of work on your part.
Yes, definitely.
You make a great point, but I disagree with the “dead money” part. To much info coming and the potential partners for AZ just got all the info they need to want a piece of this. Once the short covering manipulation is over, we will rise quickly and with partnership announcement we rocket. No knowledgeable owner of this stock should have a worry in the world about their investment.
Go back to sleep, it was only a dream.
Best analysis presented here. Exactly what is going on.
When it is done led by the hedges and their minions it does move the stock price. Ask nwbo and Sava. Plenty of proof you are wrong.
Bull. All this FUD driving doubt, and then hedges wash trading down to try and cover their shorts before this thing explodes. If your in, just relax, if your short, hurry.
Pray tell, what was wrong about Misslings answers?
I already did. Everyone should.
Please explain how any shorting is good for the market. I don’t agree that it is necessary to have liquidity, so help me understand your position on this. From my point of view, liquidity is created by company performance and news as well as sector movement, but shorting just causes unexpected volatility that is not good for investors, just day traders.
I just turned 60 and must admit, I didn’t know there was an app. Thanks and replying from it now. I really appreciate it.
It interested the author enough to take a stake in AVXL, and that is the only company he said that about.
Not bogus journalists. Possibly bogus suit by a lowlife lawyer.
Thursday, not Friday.
It’s a fact and easily researched.
Great analysis Steady.
No, they use their common sense as they see fit as do I. As far as having no common sense………
No, they use their common sense as they see fit as do I. As far as having no common sense………
Unless they have inside information, there is no data to drive a sell rating. I just use common sense, you do what you do.
More than one way to be the stand out. Just make the opposite call from everyone else and if things go south, you made a great call. This can’t be based on any facts in evidence, so probably just a longshot that if wrong will be forgotten in a few days.
I am holding 15k shares of nwbo that I bought at around 1.30 and considering buying more based on the possibility of approval this year.
Don’t say that to several here that post there as well. The company posted data lock about 2 years ago and consensus is it will get approval within 6 months or so. I was lucky and got in late but low so I am holding on.
Think NWBO.
After reading reg FD, I would say that Missling is only being cautious because of previous frivolous legal cases. Any information like this could cause a person to buy or sell securities and if so would be in breach of the reg.
I don’t think most of us took a 75% haircut, so I agree that it was a good day.
All while bringing this drug to market. Take a pill will ya?
Well said Falconer. Thanks for your reasoning and rational assessment.
I doubt that.
Is there any reason the voucher must be void just because 273 gets approval in adults since the reason for the adult trial is on the required pathway to approval for adolescents? Just thinking.
That’s the other part of that saying that most don’t know.
Well said brother.
Thanks for making that extremely easy. Done
Opinion stated as fact doesn’t make it so!
I kind of think that the FDA / Biogen interactions could lead to more two way communications driven by the FDA especially when dealing with an orphan drug for an as yet untreated condition such as Rett. If better measures are more acceptable I would hope that the fda would council a company to make approvals more likely.
I agree with traderpete, only those spreading fud seam to be complaining.
Questions asked and answered, as judges say. Let’s move on. Missling may have
added some fuel to the fire Adam stoked but never doubt that an attack was planned.
We have gotten past them before and by next week, this will just be a hiccup
on the path to real earnings.